Perimeter Medical Imaging AI Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
All right. Thanks, Andrew. Hi, everybody. Thanks for joining us today. Excited to share the Perimeter story with you all. Before I dive in, just a quick disclaimer that throughout the presentation, I will be making forward-looking statements and would direct you to our SEDAR filings for a complete discussion of risks to the organization.
And with that, diving in -- Perimeter Medical Imaging AI. We're an early commercial stage medical device company, and we're driven to transform cancer surgery with ultra-high resolution and real-time advanced imaging tools. And we're using those imaging tools to address a variety of unmet needs. But our beachhead market is an unmet need called interoperative margin assessment.
And what that means is in a solid cancer surgery -- so think breast lumpectomy -- the surgeon would remove the tumor specimen from the patient and then they send that specimen to a pathology lab that can take anywhere from two days to up to over a week to examine that specimen for any cancer at the edge -- any cancer at the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |